EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Could an outcome-based agreement be operationalized using real-world data from the Canadian Neuromuscular Disease Registry? Perspectives from an expert-led assessment in spinal muscular atrophy

Arif Mitha iD, Victoria Hodgkinson, Susi Vander Wyk, Chris Cameron, Allison Wills iD

Therapeutic Advances in Rare Disease · 2026-03 · 7

DOI: 10.1177/26330040261433035 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Therapeutic Advances in Rare Disease, online erschienen am 25.03.2026. Verfasst von Arif Mitha und 4 weiteren Autor:innen. Beteiligte Einrichtung: 20Sense, Toronto, ON, Canada. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Real-World Evidence and Outcomes-Based Agreements Working Group, abbvie, amgen.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Outcome-based agreements (OBAs) may facilitate earlier patient access to promising therapies, particularly when evidence is limited. The authors of this paper investigated how to operationalize an OBA using real-world data (RWD) from the Canadian Neuromuscular Disease Registry (CNDR).

Objective

The first objective of this research was to determine which spinal muscular atrophy (SMA) health outcomes in the CNDR are suitable for an OBA. The second objective was to evaluate the current process of data collection in the CNDR and explore how to operationalize data processes to support an OBA, including identifying gaps and proposing solutions.

Design

This qualitative expert-led assessment was conducted through a series of focus group discussions with selected experts.

Methods

A selected group of experts participated in 17 focus group meetings. The ability of the CNDR to generate real-world evidence (RWE) for an OBA was evaluated for eight SMA health outcomes. The criteria used were data readiness, interpretability, and timeframe within the CNDR. Next, the processes involved were evaluated, specifically to determine how data tracking within the CNDR could be operationalized for an OBA, including identifying gaps and possible solutions. Based on the findings, the group proposed a future state for an OBA process using the CNDR. The group followed up with stakeholder feedback interviews to validate the findings of this research and to gather insights.

Results

Five SMA outcomes within the CNDR were identified as potentially suitable outcomes for OBA. Three process gaps were identified in the current state of the CNDR, and corresponding solutions were proposed. A proposed future-state process flow for CNDR was developed to support RWE generation for OBA.

Conclusions

Expert consultations suggest that operationalizing an OBA using CNDR RWD is feasible.

Schlagwörter

Stichwörter der Autor:innen

Canadian Neuromuscular Disease Registryaccess to medicationsoutcomes-based agreementsrare diseasereal world datareimbursementspinal muscular atrophy

Autor:innen und Institutionen

  • 20Sense, Toronto, ON, Canada.
  • Department of Clinical Neurosciences, University of Calgary, Calgary, AB, Canada.
  • Hotchkiss Brain Institute, University of Calgary, Calgary, AB, Canada.
  • Cure SMA Canada Society, Chilliwack, BC, Canada.
  • EVERSANA Life Science Services LLC, Chicago, IL, USA.

ORCID-Profile: Arif Mitha, Allison Wills

Förderung

  • Real-World Evidence and Outcomes-Based Agreements Working Group
  • abbvie
  • amgen
  • astrazeneca
  • Janssen
  • pfizer
  • roche

Zitieren

APA

Mitha, A., Hodgkinson, V., Vander Wyk, S., Cameron, C., & Wills, A. (2026). Could an outcome-based agreement be operationalized using real-world data from the Canadian Neuromuscular Disease Registry? Perspectives from an expert-led assessment in spinal muscular atrophy. Therapeutic Advances in Rare Disease, 7. https://doi.org/10.1177/26330040261433035

Vancouver

Mitha A, Hodgkinson V, Vander Wyk S, Cameron C, Wills A. Could an outcome-based agreement be operationalized using real-world data from the Canadian Neuromuscular Disease Registry? Perspectives from an expert-led assessment in spinal muscular atrophy. Therapeutic Advances in Rare Disease. 2026;7. doi:10.1177/26330040261433035

BibTeX
@article{Mitha2026,
  author = {Mitha, Arif and Hodgkinson, Victoria and Vander Wyk, Susi and Cameron, Chris and Wills, Allison},
  title = {Could an outcome-based agreement be operationalized using real-world data from the Canadian Neuromuscular Disease Registry? Perspectives from an expert-led assessment in spinal muscular atrophy},
  journal = {Therapeutic Advances in Rare Disease},
  year = {2026},
  volume = {7},
  doi = {10.1177/26330040261433035}
}
Kostenlos starten →